Matrix Trust Company’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Matrix Trust Company's LLY Position: Q3 2026 in Review
Matrix Trust Company increased its Eli Lilly (LLY) stake by 10% in Q3 2026, buying an estimated $324K and bringing the position to 2,931 shares worth $3.39M. The position accounts for 0.49% of the portfolio, ranked #31.
Matrix Trust Company first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Matrix Trust Company held 2,931 shares of Eli Lilly worth $3.39M as of Q3 2026.
- Matrix Trust Company bought 275 Eli Lilly shares in Q3 2026, an estimated $324K.
- Eli Lilly made up 0.49% of Matrix Trust Company's portfolio in Q3 2026, its #31 holding.
- Matrix Trust Company first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
- 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Matrix Trust Company's 13F filing for Q3 2026, filed 7 Oct 2026.